NASDAQ · Biotechnology
Medicus Pharma Ltd. (MDCX) Stock
$0.09
-9.72%
NASDAQ: MDCX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
UGG's cozy bedding set is on rare sale for $70 at Macy's
TheStreet · Jul 17, 2026
Emmy Predictions: What Happens When One Network Has the Two Most-Nominated Series?
Variety · Jul 17, 2026
Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Scrubbed
Investor's Business Daily · Jul 17, 2026
BuzzFeed, Inc. Appoints Stanley E. Washington to Board of Directors
Business Wire · Jul 17, 2026
US to Impose 25% Section 301 Tariff on Certain Brazilian Imports
MT Newswires · Jul 17, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held12.48%
Institutions Held4.08%
Institutions Float Held4.67%
Peer Comparison
About Medicus Pharma Ltd.
Medicus Pharma Ltd. is led by CEO Raza Bokhari, employs 12 people, headquartered in CA, publicly traded since 2024.
Medicus Pharma Ltd. (MDCX) stock trades at $0.09 with a market capitalization of $5.81M. The stock is valued at a price-to-earnings (P/E) ratio of -0.06, price-to-book of -4.08, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.08 and $139.00, and currently trades 99.9% below its 52-week high.
On profitability, Medicus Pharma Ltd. generates a return on equity (ROE) of -2865.18%, return on capital employed of -329.31%, an operating margin of 0.00%, a net profit margin of 0.00%.